Use of a Markov decision process model for treatment selection in an asymptomatic disease with consideration of risk sensitivity

► We discuss the incorporation of risk sensitivity into the objective of an MDP model for treatment selection for asymptomatic chronic diseases. ► With uncertain disease parameters MDP software facilitates rapid sensitivity analysis to understand what parameters affect treatment recommendations. ► When disease parameters are uncertain custom MDP software can facilitate rapid sensitivity analysis to understand what parameters could affect treatment recommendations.